Adopting the ‘365 breathing technique’ helped reduce intraocular pressure (IOP) in primary openangle glaucoma patients, a new study has found.

Positive top-line results have been announced from a confirmatory clinical study for AVT06, a biosimilar to Eylea (aflibercept) developed by the biotech Alvotech.

Autonomous artificial intelligence (AI) systems for diagnosing diabetic eye disease (DED) have the potential to increase DED screening rates in underserved youth, while also

Australian company Eyerising International has rejected as “inaccurate” and “misleading”, an article by United States researchers about the safety of low-level redlight (LLRL) treatment